• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

将肿瘤事件的维度定义为异常运作的可变剪接。

Given dimensions of neoplastic events as aberrantly operative alternative splicing.

作者信息

Agius Lawrence M

机构信息

27 "Ballarat", Guzeppe Caruana Str., Tal-Virtu, Rabat RBT09, Malta.

出版信息

Patholog Res Int. 2010;2010:509245. doi: 10.4061/2010/509245. Epub 2009 Oct 12.

DOI:10.4061/2010/509245
PMID:21151513
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2990399/
Abstract

The provision of dynamic splicing events constitutes the reflected nature of neoplasia that locally infiltrates and systemically spreads in terms of evolutionary attributes of the primary and various secondary pathways in malignant transformation. The significant diversity in molecular characterization of the given tumor lesion would adaptively conform to dynamics of splicing as enhanced or silenced exons of the premessenger RNA molecule. The proteins synthesized are in turn potential modifiers in further gene expression within such contexts as RNA:protein and RNA:DNA binding events. The recognition of pathways of incremental scope would underline the development of lesions, such as tumors, as multiple alternative splicing phenomena primarily affecting molecular physicochemical identity. It is within contexts of operative intervention and modification that the real identity of the malignant neoplastic process arises, within terms of reference of contextual splicing events. Disrupted gene expression is thus a referential pathway in the modification of splicing that may prove constitutive or alternative, in first instance, but also aberrant as the lesion progresses locally and systemically.

摘要

动态剪接事件的发生构成了肿瘤形成的反映性本质,就恶性转化中主要和各种次要途径的进化属性而言,肿瘤会在局部浸润并在全身扩散。特定肿瘤病变分子特征的显著多样性会适应性地顺应剪接动态,即前体信使RNA分子中外显子的增强或沉默。所合成的蛋白质进而会在诸如RNA:蛋白质和RNA:DNA结合事件等背景下成为进一步基因表达的潜在调节因子。对范围不断扩大的途径的认识将突显病变(如肿瘤)的发展,即主要影响分子物理化学特性的多种可变剪接现象。正是在手术干预和修饰的背景下,恶性肿瘤形成过程的真实本质才会在上下文剪接事件的参考范围内显现出来。因此,基因表达失调是剪接修饰中的一条参考途径,最初可能是组成性或选择性的,但随着病变在局部和全身的进展也会出现异常。

相似文献

1
Given dimensions of neoplastic events as aberrantly operative alternative splicing.将肿瘤事件的维度定义为异常运作的可变剪接。
Patholog Res Int. 2010;2010:509245. doi: 10.4061/2010/509245. Epub 2009 Oct 12.
2
The role of alternative splicing in cancer: From oncogenesis to drug resistance.可变剪接在癌症中的作用:从致癌作用到耐药性。
Drug Resist Updat. 2020 Dec;53:100728. doi: 10.1016/j.drup.2020.100728. Epub 2020 Sep 28.
3
Coregulation of alternative splicing by hnRNPM and ESRP1 during EMT.在 EMT 过程中,hnRNPM 和 ESRP1 对可变剪接的共同调控。
RNA. 2018 Oct;24(10):1326-1338. doi: 10.1261/rna.066712.118. Epub 2018 Jul 24.
4
Involvement of splicing factor-1 in beta-catenin/T-cell factor-4-mediated gene transactivation and pre-mRNA splicing.剪接因子-1参与β-连环蛋白/T细胞因子-4介导的基因反式激活及前体mRNA剪接。
Gastroenterology. 2007 Mar;132(3):1039-54. doi: 10.1053/j.gastro.2007.01.007. Epub 2007 Jan 5.
5
Alternative splicing of SLC39A14 in colorectal cancer is regulated by the Wnt pathway.SLC39A14 在结直肠癌中的可变剪接受 Wnt 通路调控。
Mol Cell Proteomics. 2011 Jan;10(1):M110.002998. doi: 10.1074/mcp.M110.002998. Epub 2010 Oct 11.
6
CRKL regulates alternative splicing of cancer-related genes in cervical cancer samples and HeLa cell.CRKL 调节宫颈癌样本和 HeLa 细胞中与癌症相关基因的可变剪接。
BMC Cancer. 2019 May 27;19(1):499. doi: 10.1186/s12885-019-5671-8.
7
Aberrant posttranscriptional processing of hyaluronan synthase 1 in malignant transformation and tumor progression.透明质酸合酶 1 在恶性转化和肿瘤进展中的异常转录后加工。
Adv Cancer Res. 2014;123:67-94. doi: 10.1016/B978-0-12-800092-2.00003-4.
8
Cancer-Associated Perturbations in Alternative Pre-messenger RNA Splicing.癌症相关的前体信使核糖核酸可变剪接扰动
Cancer Treat Res. 2013;158:41-94. doi: 10.1007/978-3-642-31659-3_3.
9
A genome landscape of SRSF3-regulated splicing events and gene expression in human osteosarcoma U2OS cells.人骨肉瘤U2OS细胞中SRSF3调控的剪接事件和基因表达的基因组图谱。
Nucleic Acids Res. 2016 Feb 29;44(4):1854-70. doi: 10.1093/nar/gkv1500. Epub 2015 Dec 23.
10
AS-Quant: Detection and Visualization of Alternative Splicing Events with RNA-seq Data.AS-Quant:利用 RNA-seq 数据检测和可视化可变剪接事件。
Int J Mol Sci. 2021 Apr 25;22(9):4468. doi: 10.3390/ijms22094468.

本文引用的文献

1
Impact of BRCA1 and BRCA2 variants on splicing: clues from an allelic imbalance study.BRCA1 和 BRCA2 变异对剪接的影响:来自等位基因失衡研究的线索。
Eur J Hum Genet. 2009 Nov;17(11):1471-80. doi: 10.1038/ejhg.2009.89. Epub 2009 May 27.
2
Differential splicing using whole-transcript microarrays.使用全转录本微阵列进行差异剪接分析。
BMC Bioinformatics. 2009 May 22;10:156. doi: 10.1186/1471-2105-10-156.
3
Alternative splicing in lung cancer.肺癌中的可变剪接
J Thorac Oncol. 2009 Jun;4(6):674-8. doi: 10.1097/JTO.0b013e3181a520dc.
4
Enhanced exon-skipping induced by U7 snRNA carrying a splicing silencer sequence: Promising tool for DMD therapy.携带剪接沉默子序列的U7小核RNA诱导增强的外显子跳跃:杜氏肌营养不良症治疗的有前景工具。
Mol Ther. 2009 Jul;17(7):1234-40. doi: 10.1038/mt.2009.113. Epub 2009 May 19.
5
The do's and don'ts of p53 isoforms.p53 异构体的注意事项。
Biol Chem. 2009 Oct;390(10):951-63. doi: 10.1515/BC.2009.093.
6
Aberrant splice variants of HAS1 (Hyaluronan Synthase 1) multimerize with and modulate normally spliced HAS1 protein: a potential mechanism promoting human cancer.透明质酸合酶1(HAS1)的异常剪接变体与正常剪接的HAS1蛋白多聚化并对其进行调节:一种促进人类癌症的潜在机制。
J Biol Chem. 2009 Jul 10;284(28):18840-50. doi: 10.1074/jbc.M109.013813. Epub 2009 May 18.
7
DNA damage regulates alternative splicing through inhibition of RNA polymerase II elongation.DNA损伤通过抑制RNA聚合酶II的延伸来调控可变剪接。
Cell. 2009 May 15;137(4):708-20. doi: 10.1016/j.cell.2009.03.010.
8
Cancer-associated regulation of alternative splicing.癌症相关的可变剪接调控
Nat Struct Mol Biol. 2009 Jun;16(6):670-6. doi: 10.1038/nsmb.1608. Epub 2009 May 17.
9
Structural insights into RNA splicing.RNA剪接的结构见解。
Curr Opin Struct Biol. 2009 Jun;19(3):260-6. doi: 10.1016/j.sbi.2009.04.002. Epub 2009 May 13.
10
A hierarchical Bayesian model for comparing transcriptomes at the individual transcript isoform level.一种用于在单个转录本异构体水平上比较转录组的分层贝叶斯模型。
Nucleic Acids Res. 2009 Jun;37(10):e75. doi: 10.1093/nar/gkp282. Epub 2009 May 5.